SEARCH

SEARCH BY CITATION

References

  • 1
    Burger M, Zaak D, Stief CG et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 2007; 52: 142147
  • 2
    Sylvester RJ, van der Meijden AP, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466477; discussion 475–7
  • 3
    HESonline. HES Analysis: Main Procedures and Interventions. 2010. Available at: http://www.hesonline.nhs.uk. Accessed 8 July 2011
  • 4
    Derrington MC, Smith G. A review of studies of anaesthetic risk, morbidity and mortality. Br J Anaesth 1987; 59: 815833
  • 5
    Fowkes FG, Lunn JN, Farrow SC, Robertson IB, Samuel P. Epidemiology in anaesthesia. III: mortality risk in patients with coexisting physical disease. Br J Anaesth 1982; 54: 819825
  • 6
    Noordzij PG, Poldermans D, Schouten O, Bax JJ, Schreiner FA, Boersma E. Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology 2010; 112: 11051115
  • 7
    Gray AJG, Hoile RW, Ingram GS, Sherry KM. The Report of the National Confidential Enquiry into Perioperative Deaths. 1996/1997: 72
  • 8
    Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate and bladder cancer in the UK. BJU Int 2005; 95: 5963
  • 9
    German K, Hasan ST, Derry C. Cystodiathermy under local anaesthesia using the flexible cystoscope. Br J Urol 1992; 69: 518520
  • 10
    Herr HW. Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors. J Urol 1990; 144: 13651366
  • 11
    Holmäng S, Aldenborg F, Hedelin H. Extirpation and fulguration of multiple superficial bladder tumour recurrences under intravesical lignocaine anaesthesia. Br J Urol 1994; 73: 177180
  • 12
    Wedderburn AW, Ratan P, Birch BR. A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder. J Urol 1999; 161: 812814
  • 13
    Davenport K, Keeley FX, Timoney AG. Audit of safety, efficacy, and cost-effectiveness of local anaesthetic cystodiathermy. Ann R Coll Surg Engl 2010; 92: 706709
  • 14
    Hossain MZ, Khan SA, Salam MA, Hossain S, Islam R. Holmium YAG laser treatment of superficial bladder carcinoma. Mymensingh Med J 2005; 14: 1315
  • 15
    Hofstetter AG. Application of lasers in bladder cancer. Semin Surg Oncol 1992; 8: 214216
  • 16
    Ossoff RH, Reinisch L. Laser Surgery: Basic Principles and Safety Considerations. In Otolaryngology-Head and Neck Surgery, Cummings CW , Fredrickson JM , Harker LA , Krause CJ , Schulle DE eds, St. Louis: C.V. Mosby Company, 1993
  • 17
    Jønler M, Lund L, Bisballe S. Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia. BJU Int 2004; 94: 322325
  • 18
    Soler-Martínez J, Vozmediano-Chicharro R, Morales-Jiménez P et al. Holmium laser treatment for low grade, low stage, noninvasive bladder cancer with local anesthesia and early instillation of mitomycin C. J Urol 2007; 178: 23372339
  • 19
    Syed HA, Biyani CS, Bryan N, Brough SJ, Powell CS. Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience. J Endourol 2001; 15: 625627
  • 20
    Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 2002; 168: 6771
  • 21
    O'Brien T, Thomas K. Bladder cancer: photodynamic diagnosis can improve surgical outcome. Nat Rev Urol 2010; 7: 598599
  • 22
    Kausch I, Sommerauer M, Montorsi F et al. Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis. Aktuelle Urol 2010; 41: 171177
  • 23
    Schumacher MC, Holmäng S, Davidsson T, Friedrich B, Pedersen J, Wiklund NP. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol 2010; 57: 293299
  • 24
    Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457481
  • 25
    Betty K, Jonathan S. Essential Medical Statistics, 2nd edn. Malden, Mass.: Blackwell Science Ltd, 2003
  • 26
    National Institute of Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Clinical Excellence, 2004
  • 27
    Sangster P, Kalsi V. Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity. BJU Int 2008; 102 (Suppl. 1): 1719
  • 28
    Briggs A, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006
  • 29
    Pettiti DB. Meta-Analysis, Decision Analysis and Cost Effectivness Analysis: Methods for Quantitative Synthesis in Medicine. New York: Oxford University Press, 2000
  • 30
    Office for National Statistics Statistical Bulletin. 2013. The United Kingdom Government Actuary's Department (GAD) Interim Life Tables 2009–2011. Website http://www.ons.gov.uk/ons/dcp171778_302422.pdf. Accessed 8 June 2013
  • 31
    Low VJ, Wang D, Abel PD. Survival of patients with bladder cancer from a UK hospital: a 10-year follow-up study. BJU Int 2010; 105: 16671671
  • 32
    Akagashi K, Tanda H, Kato S et al. Recurrence pattern for superficial bladder cancer. Int J Urol 2006; 13: 686691
  • 33
    Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003; 21: 13151330
  • 34
    Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 10831086
  • 35
    Babjuk M, Oosterlinck W, Sylvester R et al. Guidelines on TaT1 (Non-muscle invasive) Bladder Cancer European Association of Urology, 2010
  • 36
    Rao C, Athanasiou T. Decision Analysis. In Key Topics in Surgical Research and Methodology, Athanasiou T , Debas H , Darzi AE eds, Berlin Heidelberg: Springer-Verlag, 2010; 399410
  • 37
    Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 2005
  • 38
    Ray ER, Chatterton K, Thomas K, Khan MS, Chandra A, O'Brien TS. Hexylaminolevulinate photodynamic diagnosis for multifocal recurrent nonmuscle invasive bladder cancer. J Endourol 2009; 23: 983988